| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.19 | 7e-05 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 9e-05 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.21 | 0.0003 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |